DURANTE MANGONI, Emanuele
 Distribuzione geografica
Continente #
EU - Europa 19.943
NA - Nord America 14.105
AS - Asia 8.529
SA - Sud America 1.409
Continente sconosciuto - Info sul continente non disponibili 539
AF - Africa 124
OC - Oceania 11
Totale 44.660
Nazione #
US - Stati Uniti d'America 13.781
RU - Federazione Russa 12.412
SG - Singapore 3.403
IE - Irlanda 1.945
CN - Cina 1.599
IT - Italia 1.547
HK - Hong Kong 1.528
BR - Brasile 1.165
UA - Ucraina 1.101
GB - Regno Unito 968
VN - Vietnam 773
SE - Svezia 495
DE - Germania 469
FI - Finlandia 331
KR - Corea 298
TR - Turchia 241
IN - India 213
FR - Francia 198
GR - Grecia 192
JP - Giappone 139
CA - Canada 130
AR - Argentina 96
AT - Austria 76
BD - Bangladesh 65
MX - Messico 55
EC - Ecuador 44
NL - Olanda 41
ZA - Sudafrica 39
ID - Indonesia 36
IQ - Iraq 35
ES - Italia 28
PK - Pakistan 28
BE - Belgio 26
CR - Costa Rica 25
UZ - Uzbekistan 24
CO - Colombia 23
JM - Giamaica 23
VE - Venezuela 21
SA - Arabia Saudita 20
KE - Kenya 18
MA - Marocco 18
CL - Cile 17
HN - Honduras 17
PL - Polonia 17
PY - Paraguay 17
EU - Europa 16
SV - El Salvador 15
JO - Giordania 14
TT - Trinidad e Tobago 13
EG - Egitto 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 11
UY - Uruguay 11
MK - Macedonia 10
NI - Nicaragua 10
PR - Porto Rico 10
TN - Tunisia 10
AL - Albania 9
AU - Australia 9
DZ - Algeria 9
LT - Lituania 9
PT - Portogallo 9
GT - Guatemala 8
MY - Malesia 8
PE - Perù 8
RO - Romania 8
BO - Bolivia 7
KZ - Kazakistan 7
NP - Nepal 7
TH - Thailandia 7
BG - Bulgaria 6
BH - Bahrain 6
CZ - Repubblica Ceca 6
LB - Libano 6
SC - Seychelles 6
TW - Taiwan 6
CW - ???statistics.table.value.countryCode.CW??? 5
GP - Guadalupe 5
IL - Israele 5
AZ - Azerbaigian 4
BY - Bielorussia 4
IR - Iran 4
KG - Kirghizistan 4
RS - Serbia 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
KW - Kuwait 3
MD - Moldavia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BB - Barbados 2
BZ - Belize 2
CY - Cipro 2
Totale 44.109
Città #
Moscow 4.482
Dublin 1.940
Jacksonville 1.676
Hong Kong 1.521
San Jose 1.383
Singapore 1.357
Santa Clara 1.285
Ashburn 1.238
Chandler 1.011
Council Bluffs 867
Princeton 384
Seoul 281
Roxbury 274
Milan 251
Ho Chi Minh City 243
Hefei 213
Cambridge 208
New York 207
Boardman 188
Beijing 186
Dallas 175
Woodbridge 172
Hanoi 169
Ann Arbor 135
Medford 135
The Dalles 130
Wilmington 125
Bengaluru 96
Los Angeles 91
São Paulo 88
Mountain View 85
Nuremberg 85
Naples 84
Miano 75
Orem 72
Des Moines 71
Memphis 63
Rome 63
San Mateo 63
Atlanta 56
North Bergen 56
Nanjing 51
Da Nang 50
Frankfurt am Main 47
Munich 46
Haiphong 42
Jinan 40
Lappeenranta 39
Tokyo 36
Brooklyn 34
Belo Horizonte 33
Houston 33
Rio de Janeiro 33
Chennai 32
Marano Di Napoli 32
Chicago 31
Phoenix 30
Bologna 29
Vienna 29
Düsseldorf 28
Montreal 27
San Francisco 27
Manchester 26
Norwalk 26
Toronto 26
Brussels 24
Washington 23
Amsterdam 22
Changsha 22
Falkenstein 22
Shenyang 22
Guangzhou 21
London 21
Helsinki 20
Tashkent 20
Denver 19
Ninh Bình 19
Philadelphia 19
Shanghai 19
Boston 18
Bremen 18
Dhaka 18
Johannesburg 18
Porto Alegre 18
Brasília 17
Nanchang 17
Quito 17
Tianjin 17
Hải Dương 16
San José 16
Seattle 16
Venice 16
Bari 15
Guayaquil 15
Kunming 15
Nairobi 15
Salvador 15
Amman 14
Brescia 14
Buffalo 14
Totale 22.743
Nome #
Neurological manifestations of COVID-19 in adults and children 375
Endocardite infettiva (EI) nei tossicodipendenti ( IVDU): prevalenza del coinvolgimento del cuore sinistro e cambiamenti del profilo microbiologico 263
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 205
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 191
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 187
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections 186
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 182
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 173
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis 173
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study 172
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 171
The value of open-source clinical science in pandemic response: lessons from ISARIC 168
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 166
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. 165
A case of coagulopathy of unclear definition 163
A case of destructive infective endocarditis 162
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 162
20210 G/A prothrombin gene mutation in patients with ischemic heart disease 161
Yellow nail syndrome as a cause of unexplained edema 160
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 159
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 158
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry 158
Endocardite Infettiva da Streptococcus bovis: risultati dello Studio Endocarditi Italiano (SEI) 158
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 157
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19 156
Clinical Characteristics and Outcome of MDR/XDR Bacterial Infections in a Neuromuscular Semi-Intensive/Sub-Intensive Care Unit 154
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies 154
Caratteristiche attuali dell'endocardite infettiva in Italia: risultati dello Studio Endocarditi Italiano (SEI) 153
Adefovir treatment for chronic hepatitis B in heart transplant recipients. 153
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 153
Pharmacokinetic parameters of CAZ-AVI in the normal lung and in models of pneumonia: lessons for treatment optimization in critical care 152
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 152
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 152
Emerging Concepts on Infection of Novel Cardiac Implantable Devices 148
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 148
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 146
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 145
Epatopatia cronica ed endocardite infettiva: risultati dello studio endocardite italiano (SEI) 145
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infection diseases specialists practicing in large hospitals 144
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 143
Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies 142
Right diaphragm paralysis following cardiac radiofrequency catheter ablation for inappropriate sinus tachycardia 142
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 142
. Iperomocisteinemia in pazienti con cardiomiopatia dilatativa: relazione con i parametri di funzione cardiaca e ruolo dei polimorfismi genici predisponenti 141
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 141
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 141
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 141
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 140
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. 140
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 140
A European first: Successful heart transplant in a human immunodeficiency virus-positive recipient 140
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 140
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant 138
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 138
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 137
Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure 137
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 136
Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview 134
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 134
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 133
Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors 132
Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal 131
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 131
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 131
Short-term effective bactericidal treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 131
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study 130
Efficacy and Safety of Fosfomycin Disodium in Patients with Bacterial Infections: A Single-Center, Real-Life Clinical Study 130
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. 130
Growth hormone deficiency in patients with Duchenne/Becker muscular dystrophy: association with dilated cardiomyopathy 130
Factor V Leiden and glycoprotein IIIa PlA2 polymorphism in coronary thrombosis 130
Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii 129
Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C 129
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 129
Does this patient have COVID-19? A practical guide for the internist 129
Infective endocarditis on cardiac rhythm management devices: preliminary study on the possible pathogenic role of inherited thrombophilias 128
Viral Hepatitis C 128
Inotropes administration in patients with acute infective endocarditis and indication for urgent cardiac surgery 127
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review 127
Effects of growth hormone therapy in Becker patients with dilated cardiomyopathy 127
Rhodococcus equi as a cause of Infective Endocarditis: description of 2 clinical cases 127
Heart failure in infective endocarditis: a report from the multicenter, prospective, observational Study on Endocarditis in Italy (SEI) 127
Efficacia e sicurezza della combinazione colistina-rifampicina in confronto con la colistina in monoterapia nelle infezioni gravi da Acinetobacter baumannii MDR: risultati preliminari 127
Trapianto cardiaco non complicato in paziente con infezione da HIV 127
Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence 127
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19 126
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 126
Monkeypox infection: An update for the practicing physician 125
Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction 124
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 124
Growth hormone evaluation in patients with dystrophinopathic muscular dystrophy and dilated cardiomyopathy 124
Viability of pegIFNα-RBV for CHC in the direct acting antiviral era: a practical algorithm between efficacy and cost containment 124
Drugs and liver injury: a not to be overlooked binomial in COVID-19 124
Embolic complications in a large contemporary cohort of infective endocarditis: do we need score model? 123
Report on 509 defined cases of infectious endocarditis of the multicentric italian study (SEI) 123
Caratteristiche cliniche ed esito delle infezioni di protesi vascolari: studio di una coorte prospettica 123
Mutato spettro clinico della endocardite infettiva in persone tossicodipendenti 123
Management of carbapenem resistant Enterobacteriaceae infections 123
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 122
Utilità dell'esame colturale ed isto-patologico della valvola nell'endocardite infettiva 122
Current trends in infective endocarditis in Italy: report on 852 cases from the multicenter, prospective SEI study 122
Totale 14.622
Categoria #
all - tutte 159.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.783 0 0 0 31 686 13 29 58 62 87 151 666
2022/20233.795 368 57 22 331 381 327 25 260 1.814 36 83 91
2023/20241.621 144 45 67 90 595 136 54 74 10 20 156 230
2024/20255.346 14 55 54 159 783 701 554 569 610 1.189 403 255
2025/202621.213 693 870 1.029 1.142 1.664 11.693 1.166 947 840 487 411 271
2026/20274.922 401 713 1.898 1.910 0 0 0 0 0 0 0 0
Totale 44.660